Sun Pharmaceuticals Industries (BOM:524715) Revenue : ₹466,707 Mil (TTM As of Dec. 2023)

View and export this data going back to 1994. Start your Free Trial

What is Sun Pharmaceuticals Industries Revenue?

Sun Pharmaceuticals Industries's revenue for the three months ended in Dec. 2023 was ₹121,569 Mil. Its revenue for the trailing twelve months (TTM) ended in Dec. 2023 was ₹466,707 Mil. Sun Pharmaceuticals Industries's Revenue per Share for the three months ended in Dec. 2023 was ₹50.58. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was ₹194.39.

Good Sign:

Sun Pharmaceuticals Industries Ltd has shown predictable revenue and earnings growth.

During the past 12 months, the average Revenue per Share Growth Rate of Sun Pharmaceuticals Industries was 11.50% per year. During the past 3 years, the average Revenue per Share Growth Rate was 10.20% per year. During the past 5 years, the average Revenue per Share Growth Rate was 10.30% per year. During the past 10 years, the average Revenue per Share Growth Rate was 9.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 13 years, Sun Pharmaceuticals Industries's highest 3-Year average Revenue per Share Growth Rate was 43.40% per year. The lowest was -1.40% per year. And the median was 20.20% per year.

Sun Pharmaceuticals Industries Revenue Historical Data

The historical data trend for Sun Pharmaceuticals Industries's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sun Pharmaceuticals Industries Revenue Chart

Sun Pharmaceuticals Industries Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Revenue

Get a 7-Day Free Trial

286,862.80

323,251.70

332,330.80

384,264.20

432,788.70

Sun Pharmaceuticals Industries Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Revenue	Get a 7-Day Free Trial															111,001.40	107,255.70	117,851.50	120,031.10	121,568.60

Competitive Comparison of Sun Pharmaceuticals Industries's Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Sun Pharmaceuticals Industries's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sun Pharmaceuticals Industries's Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sun Pharmaceuticals Industries's Revenue distribution charts can be found below:

* The bar in red indicates where Sun Pharmaceuticals Industries's Revenue falls into.

Sun Pharmaceuticals Industries Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹466,707 Mil.

Sun Pharmaceuticals Industries (BOM:524715) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:

Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.

Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.

Sun Pharmaceuticals Industries Revenue Related Terms

Thank you for viewing the detailed overview of Sun Pharmaceuticals Industries's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Sun Pharmaceuticals Industries (BOM:524715) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sun Pharmaceuticals Industries Ltd (BOM:524715) » Definitions » Revenue

Traded in Other Exchanges

SUNPHARMA:India

Address

Western Express Highway, Sun House, Plot No. 201 B/1, Goregaon (East), Mumbai, MH, IND, 400 063

Website

https://www.sunpharma.com

Sun Pharmaceuticals Industries Ltd is India's largest generic pharmaceutical manufacturer and the fourth largest in the world. The company's largest markets are the U.S. and India to make up the majority of revenue. The remaining is spread across both emerging and developed markets. In addition to generics, the company also produces and distributes name-brand formulas to specific geographies. It maintains manufacturing and research and development facilities globally to serve its markets but is primarily based in India.

Sun Pharmaceuticals Industries (BOM:524715) Headlines

No Headlines